1. Home
  2. PLSE vs EFC Comparison

PLSE vs EFC Comparison

Compare PLSE & EFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • EFC
  • Stock Information
  • Founded
  • PLSE 2014
  • EFC 2007
  • Country
  • PLSE United States
  • EFC United States
  • Employees
  • PLSE N/A
  • EFC N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • EFC Real Estate
  • Sector
  • PLSE Health Care
  • EFC Finance
  • Exchange
  • PLSE Nasdaq
  • EFC Nasdaq
  • Market Cap
  • PLSE 1.1B
  • EFC 1.2B
  • IPO Year
  • PLSE 2016
  • EFC 2010
  • Fundamental
  • Price
  • PLSE $15.51
  • EFC $13.64
  • Analyst Decision
  • PLSE Buy
  • EFC Strong Buy
  • Analyst Count
  • PLSE 1
  • EFC 7
  • Target Price
  • PLSE $22.00
  • EFC $14.32
  • AVG Volume (30 Days)
  • PLSE 165.2K
  • EFC 1.3M
  • Earning Date
  • PLSE 08-12-2025
  • EFC 08-07-2025
  • Dividend Yield
  • PLSE N/A
  • EFC 11.44%
  • EPS Growth
  • PLSE N/A
  • EFC N/A
  • EPS
  • PLSE N/A
  • EFC 1.24
  • Revenue
  • PLSE N/A
  • EFC $312,485,000.00
  • Revenue This Year
  • PLSE N/A
  • EFC N/A
  • Revenue Next Year
  • PLSE $700.00
  • EFC $15.82
  • P/E Ratio
  • PLSE N/A
  • EFC $11.01
  • Revenue Growth
  • PLSE N/A
  • EFC 10.76
  • 52 Week Low
  • PLSE $13.77
  • EFC $11.12
  • 52 Week High
  • PLSE $25.00
  • EFC $14.40
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 49.97
  • EFC 54.66
  • Support Level
  • PLSE $15.22
  • EFC $13.63
  • Resistance Level
  • PLSE $17.34
  • EFC $14.07
  • Average True Range (ATR)
  • PLSE 0.88
  • EFC 0.20
  • MACD
  • PLSE 0.03
  • EFC 0.00
  • Stochastic Oscillator
  • PLSE 39.97
  • EFC 52.75

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

Share on Social Networks: